The LATTINEN INDEX (IL) for the evaluation of chronic pain: Its correlation with coping and quality of life;Utilidad del Índice de Lattinen (IL) en la evaluación del dolor crónico: Relaciones con afrontamiento y calidad de vida

Revista de la Sociedad Espanola del Dolor

Volumn 13, Issue 4, 2006, Pages 216-229

  Monsalve, Vicente ^a   Soriano, J ^b   De Andres J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; COPING BEHAVIOR; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; RELIABILITY; SEX DIFFERENCE; SHORT FORM 36; SLEEP; VALIDITY;

EID: 33751547946     PISSN: 11348046     EISSN: 11348046     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. a Edición), pp. 580-594.
2. Levendoglu F, Ogun C, Ozerbil O, et al. Gabapentin is a firts line drag for the treatment of Neuropathic Pain in Spinal Cord Injury. Spine, 2004; 29:743-751.
3. Tikiz C, Muezzinoglu T, Pirildar T, et al. Sexual dysfunction in female subjects with fibromyalgia, The Journal of Urology, 2005; 174:620-623.
4. De Andrés J, Cerdá-Olmedo G, Valía JC, et al. Use of Botulinum Toxin in the treatment of Chronic Myofascial Pain. The Clinical Journal of Pain, 2003; 19:269-275.
5. Guerra JA, Andrés MC, Bassas E, et al. Randomised trial of long term effect of acupuntura for shoulder pain. Pain, 2004; 112:289-298.
6. Vas J, Perea-Milla E, Méndez Martínez C, et al. Una búsqueda bibliográfica fallida; ¿que faltó por buscar? El caso del test de Lattinen. Aten Primaria, 2005; 36:168-170.
7. Sittl R. Transdermal buprenorphine in the treatment of chronic pain. Expert Review of Neurotherapeutics, 2005; 5:315-323.
8. Sriwatanakul K, Kelvie, Lasagna L. Studies with different types of visual analogue scales for measurement of pain. Clin Pharmacol Ther, 1983; 34:234-239.
9. Torres LM, Calderón E, Rey RM. Fentanilo transdérmico (Durogesic): características farmacológicas y aplicación clínica. Rev Soc Esp Dolor, 1999; 6:121-131.
10. Abejón D, Delgado C, Nieto C, et al. Tratamiento de la radiculopatía lumbar con radiofrecuencia pulsada. Rev Soc Esp Dolor, 2004; 11:345-352.
11. Casals M, Samper D. Epidemiología, prevalencia y calidad de vida del dolor crónico no oncológico. Estudio ITACA. Rev Soc Esp Dolor, 2004; 11:260-269.
12. Casals M, Samper D. Efectividad, tolerabilidad y calidad de vida en el tratamiento del dolor crónico no oncológico, con tramadol de liberación controlada en dosis unica diaria. Rev Soc Esp Dolor, 2004; 11:129-140.
13. Turner J, Jensen M, Romano J. Do beliefs, coping, and catastrophizing independently predict functionin in patients with chronic pain? Pain, 2000; 85:115-125.
14. Soriano J, Monsalve V. CAD: Cuestionario de Afrontamiento ante el Dolor Crónico. Rev Soc Esp Dolor, 2002; 9:13-22.
15. Lazarus R, Folkman S. Stress, appraisal and coping. 1984, NY Springer.
16. Lamé I, Peters M, Vlaeyen J, et al. Quality of life in chronic pain is more associated with beliefs about pain, than with pain intensity. European Journal of Pain, 2005; 9:15-24.
17. Merskey H, Bogduk N. Classification of Chronic Pain. IASP Press, Seatle, 1994; 39-59.
18. a Ed. Vol. 1. New York, Lea & Febiger, pp. 18-27.
19. Revill SI, Robinson JO, Roses et al. The reability of a linear analogue for evaluating. Anesthesia, 1976; 31:1191.
20. Huskisson EC. Visual Analogue Scales. En R. Melzack (Ed.): Pain Meassurement and Assessment. Raven Press, New York, 1983; pp. 33-37.
21. Carlsson AM. Assessment of Chronic Pain I. Aspects of the Reliability and Validity of the Visual Analog Scale. Pain, 1983; 16:87.
22. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, 1992; 30:473-483.
23. McHorney CA, Ware JE, Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care, 1993; 31:247-263.
24. McHorney CA, Ware JE, Lu JFR, et al. The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality. Scaling assumptions, and reliability across diverse patient groups. Med Care, 1994; 32:40-66.
25. Aaronson NK, Acquadro C, Alonso J, et al. International Quality of Life Assessment (IQOLA) Project. Quality of Life Research, 1992; 1:349-51.
26. Bullinger M, Alonso J, Apolone G, et al. Translating health status questionnaires and evaluating their quality: The International Quality of Life Assessment Project approach. J Clin Epidemiol, 1998; 51:913-923.
27. Alonso J, Regidor E, Barrio G, et al. Valores poblacionales de referencia de la versión española del Cuestionario de Salud SF-36. Med Clín, 1998; 111:410-416.
28. Conde M, Pinto-Neto AM, Cabello C, et al. Quality of life in Brazilian breast cancer survivors age 45-65 years: associated factors. Breast J, 2005; 11:425-432.
29. Jastrzebski D, Kozielski J, Banas A, et al. Quality of life during one-year observation of patients with idiopathic pulmonary fibrosis awaiting lung transplantation. J Physiol Pharmacol, 2005; 56 (Suppl 4.):99-105.
30. Jensen MP, Abresch RT, Carter GT, et al. Chronic Pain in persons with neuromuscular disease. Arch Phys Med Rehabil, 2005; 86:1155-63.
31. Laursen BS, Bajaj P, Olesen AS, et al. Health related quality of life and quantitative pain measurement in females with chronic non-malignant pain, 2005; 9:267-275.
32. Soriano J, Monsalve V. Validación del Cuestionario de Afrontamiento al Dolor Crónico Reducido (CADR). Rev Soc Esp Dolor, 2004; 11:407-414.